Get started
Author

Isha Kapoor

Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
2020 · Isha Kapoor, Juraj Bodo, et al. · Cell Death and Disease · 250
PDF
Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies
2019 · Isha Kapoor, Yue Li, et al. · Cell Death and Disease · 77
PDF
Skp2 inhibits osteogenesis by promoting ubiquitin–proteasome degradation of Runx2
2016 · Gatha Thacker, Yogesh Kumar, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 52
PDF
USP14 is a deubiquitinase for Ku70 and critical determinant of non-homologous end joining repair in autophagy and PTEN-deficient cells
2019 · Arishya Sharma, Turkeya Alswillah, et al. · Nucleic Acids Research · 47
PDF
Aberrant Splicing Induced by Dysregulated Rbfox2 Produces Enhanced Function of Ca V 1.2 Calcium Channel and Vascular Myogenic Tone in Hypertension
2017 · Yingying Zhou, Jia Fan, et al. · Hypertension · 43
E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation
2013 · Savita Lochab, Pooja Pal, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 35
PDF
E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation
2013 · P Pal, S Lochab, et al. · Cell Death and Disease · 34
PDF
E3 Ubiquitin Ligase Fbw7 Negatively Regulates Osteoblast Differentiation by Targeting Runx2 for Degradation
2015 · Yogesh Kumar, Isha Kapoor, et al. · Journal of Biological Chemistry · 31
E3 Ubiquitin Ligase E6AP Negatively Regulates Adipogenesis by Downregulating Proadipogenic Factor C/EBPalpha
2013 · Pooja Pal, Savita Lochab, et al. · PLoS ONE · 27
PDF
Proteomic identification of E 6 AP as a molecular target of tamoxifen in MCF 7 cells
2012 · Savita Lochab, Pooja Pal, et al. · PROTEOMICS · 23
Galectin-1 attenuates cardiomyocyte hypertrophy through splice-variant specific modulation of CaV1.2 calcium channel
2018 · Jia Fan, Wenyong Fan, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 22
PDF
Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiation
2015 · Isha Kapoor, Jitendra Kanaujiya, et al. · Oncotarget · 19
PDF
Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignancies
2021 · Isha Kapoor, Juraj Bodo, et al. · Cell Death and Disease · 18
PDF
Proteomic identification of P rofilin1 as a corepressor of estrogen receptor alpha in MCF 7 breast cancer cells
2013 · Jitendra Kumar Kanaujiya, Savita Lochab, et al. · PROTEOMICS · 18
SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis
2023 · Anthony Williams, Lisa Gutgesell, et al. · Cancer Letters · 16
Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner
2016 · Yogesh Kumar, Nidhi Shukla, et al. · Molecular Cancer Research · 14
Aberrant Exon 8/8a Splicing by Downregulated PTBP (Polypyrimidine Tract-Binding Protein) 1 Increases Ca V 1.2 Dihydropyridine Resistance to Attenuate Vasodilation
2020 · Jianzhen Lei, Xiaoxin Liu, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 13
Proteomics approaches for myeloid leukemia drug discovery
2012 · Isha Kapoor, Pooja Pal, et al. · Expert Opinion on Drug Discovery · 9
Differences in the proteome within extracellular vesicles between premalignant and malignant plasma cell disorders
2024 · Patrick M. Vanderboom, Yogesh Chawla, et al. · European Journal Of Haematology · 4
PDF
E6AP inhibits G-CSFR turnover and functions by promoting its ubiquitin-dependent proteasome degradation
2017 · Stuti Chhabra, Yogesh Kumar, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 4
PDF
Withdrawal: E3 ubiquitin ligase Fbw7 negatively regulates osteoblast differentiation by targeting Runx2 for degradation.
2019 · Yogesh Kumar, Isha Kapoor, et al. · Journal of Biological Chemistry · 2
PDF
Synthetic Strategies and Emerging Therapeutic Interventions of Isoxazole and its Molecular Hybrids
2026 · Monika Gupta, Isha Kapoor, et al. · Mini-Reviews in Medicinal Chemistry
Abstract P2-08-26: FLEX: A Real-World Evidence, Full Transcriptome Study in 30,000 Patients with Early-Stage Breast Cancer
2025 · Robert Maganini, Ellis Levine, et al. · Clinical Cancer Research
Molecular insights into HR+/HER2+ early-stage breast cancer: Neoadjuvant therapy responses by MammaPrint and BluePrint genomic subtypes.
2025 · Laila Samiian, Adam Brufsky, et al. · Journal of Clinical Oncology
PDF
Evaluating Differences in the Proteome Within Extracellular Vesicles Between Pre- Malignant and Malignant Plasma Cell Disorders
2023 · Patrick M. Vanderboom, Yogesh Chawla, et al. · Research Square
PDF
Works count: 26
Citation count: 758
H-index: 15
I10-index: 17
Year
Topic
Type